Pharma & Biopharma

Stefan Foser, VP of Global Pharma at Bruker, reflects on the importance of analytical technology in the “post-genomic era”

Advancements in sample preparation, coupling separations, and data collection are paving the way for broader CD-MS adoption

Why Evan Williams is surprised that more companies aren’t interested in commercializing charge-detection technologies

Where is the success of the mRNA vaccines during the COVID-19 pandemic taking the field of nucleotide-based therapies?

How handheld Raman spectroscopy instruments are making a mark in raw materials identification

NMR reveals how different siRNA mixing methods affect lipid nanoparticles’ internal structure and gene-silencing efficiency

Mass spectrometry research published in the past week: nitrosamine testing, library matching solutions, Ian Wilson honored – and more

Researchers combine tissue imaging with proteomics to shed light on the neurotoxic effects associated with HIV medication Efavirenz treatment

A new NMR method enables direct detection of molecular chirality, eliminating the need for chiral agents

CD-MS has extended the range of MS to gigadalton-sized viruses and polymers; and with a commercial instrument in development, maturity beckons